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INTRODUCTION
Currently, a variety of diagnostic methods and
treatment strategies for biliary tract carcinoma are
available. The prognosis for patients with this car-
cinoma, however, is still not as good as expected
and thus the development of novel early diagnosis
and treatment methods is desired. Although that
bile juice cytology is useful for a definite diagnosis,
this technique may give a false-negative result in
some patients with advanced cancer, and various
methods including different sampling methods, have
been tried using to improve true positive rates (1, 2-6).
MUC1 is a mucin highly expressed in tumor cells of
the digestive tract. MUC1 is sialylated in association
with cancerization of cells and is considered to play
a role as an anti-adhesion factor that inhibits cell-
to-cell adhesion including tumor cell to tumor cell
and tumor cell to extracellular matrix (7, 8). MUC2
is considered to control cell proliferation (9, 10).
There have been many studies on the relation-
ship between mucin expression and various cancer
ORIGINAL
Relationship between mucin expression and preoperative
bile juice cytology in biliary tract carcinoma
Yoshitaka Imoto１, Naoki Muguruma１, Tetsuo Kimura１, Eriko Aoyagi１, Koichi Okamoto１,
Seisuke Okamura１, Susumu Ito１, Nobuya Sano２, and Mitsuo Shimada３
１）Department of Digestive and Cardiovascular Medicine, Institute of Health Biosciences, The Uni-
versity of Tokushima Graduate School, ２）Department of Pathology, Tokushima University Hospital,
and ３）Department of Digestive and Pediatric Surgery, Institute of Health Biosciences, The Univer-
sity of Tokushima Graduate School, Tokushima, Japan
Abstract : The present study evaluated correlations between preoperative bile juice cytology
and mucin expression of surgical specimens in biliary tract carcinoma. Twenty-five patients
with biliary tract carcinoma surgically treated at our hospital, whose bile juice cytology
had been evaluated before operation, were allocated to this study. Biliary cytology was
classified into three categories based on the Papanicolaou classification. Immunohisto-
chemical staining of tissues was performed using MUC1 and MUC2 monoclonal antibodies.
Lesions showing MUC1 expression of ＋＋ or higher and MUC2 expression of - were classified
as Group A, and the remaining lesions as Group B. According to the epithelial site, pre-
operative cytology was highly correlated in Group A, while it was negative in Group B
(p<0.05). In the advanced site of carcinomas, preoperative cytology tended to highly be posi-
tive in Group A, while it tended to be negative in Group B (p<0.05). These results suggest
that the bile juice cytology results are affected by characteristics of mucin expression in the
tissue. Based on the possibility that mucin expression correlates with the prognosis of each
carcinoma, a positive cytological result suggests a poor prognosis for the carcinoma, which
may be informative for predicting the post-operative courses and choosing treatments.
J. Med. Invest. 54 : 41-47, February, 2007
Keywords : biliary tract cancer, mucin, bile juice cytology
Received for publication September 20, 2006 ; accepted Novem-
ber 24, 2006
Address correspondence and reprint requests to Naoki Muguruma,
Department of Digestive and Cardiovascular Medicine, Insti-
tute of Health Biosciences, The University of Tokushima Gradu-
ate School, Kuramoto-cho, Tokushima, 770-8503, Japan and
Fax : +81-88-633-9235
The Journal of Medical Investigation Vol. 54 2007
４１
prognoses (7, 8, 11-13), and we reported that mucin
expression in surgically obtained biliary tract car-
cinoma specimens was closely related to survival
prognosis (14). To our knowledge, however, there
are no studies evaluating the relationship between
mucin expression and the results of cytological ex-
amination for any type of cancer. Therefore, we con-
ducted this study to examine whether mucin ex-
pression is a factor contributing to the results of
cytological examination of aspirated bile juice in
patients with biliary tract carcinoma.
METHODOLOGY
Materials
Twenty-five patients with biliary tract carcinoma
(14 males, 11 females ; gallbladder carcinoma : 13
cases, cancer of the ampulla of Vater : one case,
cancer of the common bile duct : seven cases and
hepatic hilar cholangiocarcinoma : four cases) sur-
gically treated at our hospital and whose bile juice
cytology had been evaluated before operation were
allocated to this study. Gallbladder cancer stages
were evaluated according to the TNM Classifica-
tion of Malignant Tumors (ICD-O C23, 24.0 and 24.1)
of the UICC. All patients approved the study with
informed consent.
Cytological examination
Cytological examination of bile juice was per-
formed three times or until a specimen showed a
positive reaction according to the Papanicolaou clas-
sification system. Two experienced cytologists ex-
amined all samples to determine whether they con-
tained malignant cells. Specimens of bile juice as-
piratate or effluent were obtained by percutaneous
transhepatic cholangiodrainage (PTCD), percuta-
neous transhepatic gallbladder drainage (PTGBD),
or endoscopic nasobiliary drainage (ENBD) and kept
on ice in an ice box and promptly submitted to the
clinical laboratory for examination. Biliary cytology
was classified into three categories based on the
Papanicolaou classification : negative, suspicious and
positive.
Mucin immunohistochemistry
Serial sections were immunostained with mono-
clonal antibodies against MUC1 and MUC2. For
immunostaining of mucin, antibodies MY.1E12
(kindly provided by Prof. Tatsuro Irimura, The Uni-
versity of Tokyo) and CCP58 (Pharmingen Co. Ltd.,
San Diego, CA) were diluted 100 and 50 times, re-
spectively, before application. To enhance the im-
munoreactivity of CCP58, sections were pretreated
in a microwave oven ; deparaffinized sections were
transferred to 0.01M citrate buffer at pH 6, and were
heated in a 500W microwave oven for 12 min. To
inactivate endogenous peroxidase, all sections were
treated in methanol containing 3% hydrogen per-
oxidase for 10 min. After washing with PBS, the sec-
tions were incubated overnight at 4℃ with each
monoclonal antibody. They were then washed with
PBS, and incubated with biotinylated goat anti-rabbit
IgG antibody (Vector Laboratories, Inc., Burlingame,
CA, USA) and avidin-biotinylated complex for 40 min
at room temperature. The reactions were visualized
by staining with 3-3` diaminobenzidine, and the sec-
tions were counter stained with hematoxylin.
The immunoreactivity of each antibody was graded
on the extent of staining of cancer cells : 0% (-), 1-
10% (+), 11-50% (++), 50%< (+++). Lesions showing
MUC1 expression of ++ or higher and MUC2 ex-
pression of - were classified as belonging to Group
A, and the remaining lesions as belonging to Group
B. Because mucin expression of the infiltrative lesion
of the cancer differed from mucin expression in the
intra-epithelial lesion, the mucin expression was as-
sessed separately in each part.
Statistical Analysis
Categorical data were analyzed using chi-square
test and p values of <0.05 were considered signifi-
cant.
RESULTS
Bile juice cytology
A total of 40 specimens for bile juice cytology were
collected from 25 patients (a mean number of cyto-
logical examinations per patient, 1.6). Ten (40.0%)
of the 25 patients studied showed positive cytol-
ogy (Table 1). As mentioned above, patients un-
derwent preoperative bile cytology up to three
times. No significant relationship was demonstrated
between the number of cytological examinations and
their results ; six patients showed a positive result
in a single test but three remained suspicious in all
three tests (Table 2). Evaluation of the relationship
between clinical stage and the results of bile juice
cytology yielded no significant relationship ; three
patients at clinical stage I or early-stage biliary
tract carcinoma showed positive cytology, but four
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at clinical stage IV, or an advanced stage, revealed
suspicious or negative cytology (Table 3).
Mucin-expression group and its relationship to the
cytological results
There was no significant relationship between the
extent of each mucin expression in the intra-
epithelial lesion and the cytological results of bile
juice. No significant relationship was also found
between the expression of MUC1 alone or MUC2
alone in the infiltrative lesion and the cytological
results. Then, the evaluation was performed after
categorizing each portion into Group A and B based
on the extent of mucin expression. In the intra-
Table 2. Correlation between cytological results and the num-
ber of examinations
Cytological
results
Number of examinations
1 2 3
Positive
6 3 1
(n=10)
Suspicious
2 3 3
(n=8)
Negative
6 1 0
(n=7)
Total
14 7 4
(n=25)
Table 3. Correlation between clinical stage and cytological re-
sults
Cytology
Clinical stage
0 IA, IB IIA, IIB III IV
Positive
0 3 6 1 0
(n=10)
Suspicious
0 3 1 1 3
(n=8)
Negative
2 1 2 1 1
(n=7)
Total
2 7 9 3 4
(n=25)
Table 1. Mucin staining results of 25 patients with biliary tract carcinoma
Case Age/Sex Diag. Stage HPG CytologyClass/Exam.
Intra-epithelial lesion Infiltrative lesion
MUC1/MUC2 MUC1/MUC2
1 65/M CBD IIA G1 5/2 ＋＋＋/－ ＋＋＋/－
2 65/F GB IIB G2 4/1 ＋＋＋/－ ＋＋＋/－
3 48/F GB III G1 2/2 ＋＋＋/＋ ＋＋＋/＋
4 64/M GB IIB G2 4/2 ＋＋＋/－ ＋＋＋/－
5 73/M GB 0 G1 2/1 ＋＋/＋ ＋＋/－
6 78/F GB IB G3 4/1 ＋/＋ ＋＋＋/＋
7 72/M GB IA G1 5/1 ＋＋＋/－ ＋＋/－
8 61/F GB IIA G1 2/1 ＋/＋＋＋ ＋/＋＋
9 71/M GB IV G4 3/1 ＋/－ ＋/－
10 79/F GB IIB G1 2/1 ＋＋/＋＋＋ ＋＋＋/＋＋＋
11 62/F GB IB G1 3/2 ＋＋/＋＋ ＋/－
12 74/F GB IB G1 2/1 ＋＋＋/－ ＋＋/－
13 61/M HHC IIB G2 5/3 ＋＋＋/－ ＋＋＋/－
14 66/M CBD IV G1 3/2 ＋＋＋/＋＋＋ ＋＋＋/＋
15 52/M AV III G2 3/2 －/＋ －/－
16 75/F CBD IA G2 5/1 ＋＋＋/＋＋ ＋＋＋/－
17 61/F HHC IV G2 2/1 ＋＋/－ ＋＋/－
18 46/M CBD IIA G1 3/3 ＋＋/＋ ＋＋＋/＋
19 64/M CBD IIB G2 5/1 ＋＋/－ ＋＋/－
20 57/M HHC IB G1 3/3 ＋/－ ＋/－
21 40/M GB 0 G1 1/1 ＋＋＋/－ ＋＋＋/－
22 67/M CBD III G1 5/2 ＋＋/－ ＋＋/－
23 76/F CBD IA G1 3/3 ＋＋＋/－ ＋＋＋/－
24 71/F GB IV G1 3/1 ＋/－ －/－
25 62/M HHC IIB G2 5/1 ＋＋/－ ＋/－
GB : gallbladder carcinoma, AV : cancer of the ampulla of Vater, CBD : cancer of the common bile duct
HHC : hepatic hilar cholangiocarcinoma, HPG : Histopathological Grading
G1 : Well differentiated, G2 : Moderately differentiated, G3 : Poorly differentiated, G4 : Undifferentiated
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epithelial lesion of the cancer, 12 patients were in
Group A, including 8 patients who were positive
for cytology test and 1 who was suspicious and 3
who were negative ; in contrast, of 13 patients in
Group B, 2 patients were positive for cytology test,
7 suspicious and 4 negative. In the infiltrative lesion,
13 patients were in Group A, including 8 patients
being positive for cytology test, 1 suspicious and 4
negative ; in contrast, of 12 patients in Group B, 2
patients were positive for cytology test, 7 suspicious
and 3 negative. These results demonstrated that
mucin expression in both the intra-epithelial and
infiltrative lesions of cancer was significantly re-
lated to the cytological results of bile juice when
each portion was classified into Group A or B based
on the extent of mucin expression (intra-epithelial
portion vs. infiltrative portion, both p=0.0164) (Table 4,
Figs. 1(A, B), 2(A, B)).
Fig. 1 : This case is a 65-year-old male with common bile duct cancer, tissue type G1, stage IIA, and class V bile juice cytology,
strongly positive for MUC1 (A) in the infiltrative lesion of cancer, and negative for MUC2 (B), and was Group A for the extent of
mucin expression.
Fig. 2 : This case is a 61-year-old female with gallbladder carcinoma, tissue type G1, stage IIA, and class II bile juice cytology, mildly
positive for MUC1 (A) in the intra-epithelial lesion of the cancer, and strongly positive for MUC2 (B), and was Group B for the
extent of mucin expression.
Table 4. Correlation between mucin expression group and cy-
tological results
Positive Suspicious Negative
Intra-epithelial
lesion
Group A
8 1 3
＊
(n=12)
Group B
2 7 4
(n=13)
Infiltrative
lesion
Group A
8 1 4
＊
(n=13)
Group B
2 7 3
(n=12)
＊ : p<0.05
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DISCUSSION
Today, imaging diagnosis has progressed con-
siderably. However, in many cases it is still diffi-
cult to determine whether the cause of a biliary tract
disorder, especially stenosis, is malignant or be-
nign. In such cases, the results of bile juice cytol-
ogy, specimens of which are obtained via endoscopic
retrograde cholangiopancreatography (ERCP) or per-
cutaneous transhepatic biliary drainage (PTBD), will
provide information. Although bile exfoliative cy-
tology is popular for the diagnosis of biliary tract
carcinoma, its sensitivity varies from 60% to 82%
(1, 2-6), and still remains inadequate (between 68%
and 76%) even when specimens are obtained by the
biliary tract brushing technique (1, 4, 5). For the
diagnosis of malignant biliary stenosis, only the tech-
nology for collecting cells has been stressed and no
attention has been paid to individual patient’s factors.
At the same time, there have been many studies
on the relationship between mucin expression and
cancer prognoses (7, 8, 11-13). Mucin is a major
secretory component of mucus produced by epi-
thelial cells and is considered to play a role in pro-
tecting cells from the effects of extracellular sub-
stances or in lubricating cell surfaces. Abundant
recent data derived from studies on mucin pro-
duced by epithelial tumor cells have demonstrated
that one type of mucin (MUC1) also adheres to
cellular membranes. Using this feature, the exis-
tence of a relationship between the extents of ex-
pression of MUC1 and MUC2 and the prognosis
of various digestive tract cancers has been demon-
strated ; the cancers studied included gastric car-
cinoma (10, 11), colon cancer (15), gall bladder
cancer (7, 8, 14, 16), extrahepatic bile duct cancer
(12, 17), intrahepatic bile duct cancer (18), papil-
lary carcinoma (13), pancreatic cancer (9), and in-
traductal papillary mucinous tumor of the pancreas
(19) ; among the presumable features, the anti-
adhesion effect of MUC1 and cell growth-control func-
tion of MUC2 are assumed to contribute to this
association (10). Meanwhile, the relationship be-
tween mucin expression and the results of cytol-
ogy has not been explored in any type of cancer.
We hypothesized that cancer cell exfoliation re-
sults from mucin expression, and therefore we ex-
amined the relationship between mucin expression
and the results of preoperative bile juice cytology
in patients with biliary tract carcinoma.
In this study, no relationship between the number
of cytological examinations of bile and the results
of the cytology was observed, the increased num-
ber of cytological examinations was not always as-
sociated with the detection of cancer cells in bile,
and there were patients in whom cancer cells were
detected by a single examination. In further study,
we need a quantitative cytological examination of bile
juice to reassess our hypothesis more precisely be-
cause we simply implemented qualitative bile exfo-
liative cytology in this study. In addition, no signifi-
cant correlation was found in this study between the
results of bile cytology and the histopathological type
or clinical stage ; positive bile cytology was ob-
served even in patients with early stage cancer,
and contrarily, negative bile cytology was noted in
patients with advanced stage cancer, probably due
to little exfoliation of cancer cells.
Because mucin expression in the epithelial por-
tion of a cancer was reported to differ from that in
the infiltrative portion (8, 20), we also evaluated
mucin expression in both the epithelial portion near
the bile duct and the infiltrative portion. When cy-
tological specimens were classified according to the
extents of expressions of MUC1 and MUC2, the
intra-epithelial portion and the infiltrative portion
showed almost the same results ; only one patient
presented a different mucin expression group ratio,
although MUC1 and MUC2 were expressed to
different extents in different areas. Yonezawa et al.
reported that diagnosis using both MUC1 and
MUC2 would be useful to assume the prognoses
of various cancers (9, 12, 18). Our data demon-
strated a close relationship between mucin expres-
sion groups and the results of bile cytology. MUC
1 is sialylated in association with cancerization of
cells and considered to play a role as an anti-
adhesion factor that inhibits cell to cell adhesion,
including tumor cell to tumor cell and tumor cell
to extracellular matrix. Thus, MUC1 probably has
a function related to anti-adhesion (7, 8). MUC2 is
considered to control cell proliferation (9, 10). These
features probably function in the epithelium of the
bile duct. The close relationship between prognosis
of patients with biliary tract carcinoma and mucin
expression suggests that the results of bile cytol-
ogy can be a valuable marker for assessing the
prognosis of this cancer. Moreover, the results of
bile cytology classified according to the extent of
mucin expression may provide information useful
for the choice of additional treatment after surgery.
Studies using preoperative bile cytology with a
long-term follow-up are expected to support the re-
lationship that we observed in this study.
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